CellaVision AB (publ)

SSE:CEVI.ST

257 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 677.292639.34565.552471.443461.772364.812309.312265.038239.39216.916179.851169.512155.402131.638108.974100.44474.565
Cost of Revenue 214.251201.023173.25158.402125.03893.94686.09276.10265.15771.81467.22559.45653.99144.08232.48636.94129.312
Gross Profit 463.041438.317392.302313.041336.734270.866223.22188.936174.233145.102112.626110.056101.41187.55676.48863.50345.253
Gross Profit Ratio 0.6840.6860.6940.6640.7290.7420.7220.7130.7280.6690.6260.6490.6530.6650.7020.6320.607
Reseach & Development Expenses 83.33388.55364.24851.25356.41739.25326.78629.23927.12422.76520.68321.43521.40717.33612.05811.89811.137
General & Administrative Expenses 76.03273.53663.07750.96651.39437.64435.56528.6733.78836.83326.65329.0627.01323.04619.28516.46116.066
Selling & Marketing Expenses 136.624117.962102.246100.549102.34882.36269.97756.85947.85142.69139.34438.85935.28133.63730.44321.74815.135
SG&A 212.656191.498165.323151.515153.742120.006105.54285.52981.63979.52465.99767.91962.29456.68349.72838.20931.201
Other Expenses 0.00100000000000-0.09-0.411-0.0750.012-0.227
Operating Expenses 295.989280.051229.571202.768210.159159.259132.328114.768108.763102.28986.6889.35483.61173.60861.71150.11942.111
Operating Income 167.052158.266162.733110.273126.576111.60790.89274.16865.4742.81325.94620.70217.813.94814.77713.3843.142
Operating Income Ratio 0.2470.2480.2880.2340.2740.3060.2940.280.2730.1970.1440.1220.1150.1060.1360.1330.042
Total Other Income Expenses Net -2.83-9.837-4.4361.9552.6440.49-0.5491.6070.0830.556-1.256-2.1510.714-3.224-0.616-0.33-0.517
Income Before Tax 164.222148.429158.297112.228129.22112.09790.34375.77565.55343.36924.6918.55118.51410.72414.16113.0542.625
Income Before Tax Ratio 0.2420.2320.280.2380.280.3070.2920.2860.2740.20.1370.1090.1190.0810.130.130.035
Income Tax Expense 33.91330.09432.95822.74830.04823.40820.6215.97512.73111.9045.75812.13.881-27.625-13.559-120
Net Income 130.309118.335125.33989.4899.17288.68869.72359.852.82231.46518.9326.45114.63338.34927.7225.0542.625
Net Income Ratio 0.1920.1850.2220.190.2150.2430.2250.2260.2210.1450.1050.0380.0940.2910.2540.2490.035
EPS 5.464.965.253.754.163.722.922.512.221.320.790.270.611.611.161.050.11
EPS Diluted 5.464.965.253.754.163.722.922.512.221.320.790.270.611.611.161.050.11
EBITDA 199.815190.866193.6146.812150.87119.06398.95184.07373.13556.87533.99826.67718.91313.94814.79213.7473.402
EBITDA Ratio 0.2950.2990.3420.3110.3270.3260.320.3170.3060.2620.1890.1570.1220.1060.1360.1370.046